Sector revisions Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE Other stock markets 16:00:02 2026-07-01 EDT			Pre-market 09:20:00
229.09 ^USD	+1.01%		228.12	-0.42%

07-01	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
07-01	Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		15
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		22
IQVIA HOLDINGS INC.		19
BEONE MEDICINES AG		27
CELLTRION, INC.		24
ASCENDIS PHARMA A/S	-	18
MEDPACE HOLDINGS, INC.		12
EUROFINS SCIENTIFIC SE		14
ICON PUBLIC LIMITED COMPANY		16
IONIS PHARMACEUTICALS, INC.		23
BIO-TECHNE CORPORATION		12
ABIVAX		6
TEMPUS AI, INC.		16
APOGEE THERAPEUTICS, INC.		12
KYMERA THERAPEUTICS, INC.		21
PRAXIS PRECISION MEDICINES, INC.		18
ALKERMES PLC		16
QIAGEN N.V.		14
IMMUNOVANT, INC.		17
Average		17
Weighted average by Cap.		19